SS-31, also known as Elamipretide, is a mitochondria-targeting peptide designed to improve cellular energy production and reduce oxidative stress. Unlike many peptides that work through hormone receptors, SS-31 binds to cardiolipin within the inner mitochondrial membrane, helping stabilize mitochondrial function and improve ATP production. It has been extensively studied for age-related decline, cardiovascular health, muscle performance, fatigue, metabolic disorders, and mitochondrial dysfunction.
Common Research Dosing Protocol:
2-5 mg daily
Common starting dose: 2 mg daily
Typical performance/recovery protocol: 5 mg daily
Typical cycle length: 4-12 weeks
Administration:
Subcutaneous injection
Usually administered once daily
Often taken in the morning due to reports of increased energy and reduced fatigue
Storage:
Refrigerate at 36-46°F (2-8°C) after reconstitution
Protect from light
Do not freeze
Use sterile technique for all withdrawals
Notes:
SS-31 is frequently researched for:
Mitochondrial function and ATP production
Exercise endurance and recovery
Reduction of oxidative stress
Cardiovascular support
Healthy aging
Improved metabolic efficiency
It is commonly stacked with MOTS-c, AICAR, Retatrutide, or Tesamorelin in metabolic and performance-focused protocols. Many users report improvements in energy levels, workout endurance, recovery capacity, and reduced fatigue within 1-3 weeks, though mitochondrial adaptations may continue to develop over longer periods. Unlike stimulants, SS-31 typically enhances cellular energy production without causing jitters or elevated heart rate.
SS-31, also known as Elamipretide, is a mitochondria-targeting peptide designed to improve cellular energy production and reduce oxidative stress. Unlike many peptides that work through hormone receptors, SS-31 binds to cardiolipin within the inner mitochondrial membrane, helping stabilize mitochondrial function and improve ATP production. It has been extensively studied for age-related decline, cardiovascular health, muscle performance, fatigue, metabolic disorders, and mitochondrial dysfunction.
Common Research Dosing Protocol:
2-5 mg daily
Common starting dose: 2 mg daily
Typical performance/recovery protocol: 5 mg daily
Typical cycle length: 4-12 weeks
Administration:
Subcutaneous injection
Usually administered once daily
Often taken in the morning due to reports of increased energy and reduced fatigue
Storage:
Refrigerate at 36-46°F (2-8°C) after reconstitution
Protect from light
Do not freeze
Use sterile technique for all withdrawals
Notes:
SS-31 is frequently researched for:
Mitochondrial function and ATP production
Exercise endurance and recovery
Reduction of oxidative stress
Cardiovascular support
Healthy aging
Improved metabolic efficiency
It is commonly stacked with MOTS-c, AICAR, Retatrutide, or Tesamorelin in metabolic and performance-focused protocols. Many users report improvements in energy levels, workout endurance, recovery capacity, and reduced fatigue within 1-3 weeks, though mitochondrial adaptations may continue to develop over longer periods. Unlike stimulants, SS-31 typically enhances cellular energy production without causing jitters or elevated heart rate.